Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2016 Settembre;58(3) > Panminerva Medica 2016 Settembre;58(3):237-41

ULTIMO FASCICOLOPANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

REVIEWS  


Panminerva Medica 2016 Settembre;58(3):237-41

lingua: Inglese

Pathogenesis and treatment options for intradialytic hypertension

Ana ROCHA

São Francisco Dialysis Unit, Porto, Portugal


PDF  ESTRATTI


Controversy surrounds the diagnosis and treatment of intradialytic hypertension. Here, we describe the definition, epidemiology and management of intradialytic hypertension. Although this hemodialysis complication has long been recognized, only recently it was associated with increased morbidity and mortality in dialysis patients. Endothelial cell dysfunction appears to be the major mechanism underlying this blood pressure phenomenon, and the role of extracellular volume and sodium overload remains to be better defined. To treat this potential cardiovascular health threat is necessary to identify and understand the factors that influence it.

inizio pagina